The parallel discovery of multiple scaffolds useful to antagonize the cancer-relevant protein–protein interaction p53/Hdm2 is described. The new method is based on the tightly interwoven interplay of multicomponent reaction chemistry, structural biology, computational chemistry, and high-content NMR-based screening.
No takes yet. Share an insight, caveat, or question.
Czarna et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: